Colorectal Cancer Clinical Trials in San Francisco

Showing 141-160 of 186 trials

A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

NCT00873756

This is a multicenter, open-label study enrolling a total of up to 23 patients.

Genentech, Inc.23 participantsStarted May 2009

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)

NCT01374425

This will be a randomized, open-label, multicenter, Phase II study with primary objectives to assess whether expression of select chemotherapy markers is associated with progression-free survival (PFS) in participants treated with bevacizumab plus leucovorin, 5-fluorouracil, and oxaliplatin (mFOLFOX6) or bevacizumab plus leucovorin, 5-fluorouracil, and irinotecan (FOLFIRI). The study population will consist of participants with first-line mCRC.

Colorectal Cancer

Genentech, Inc.376 participantsStarted Aug 2011

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Bellflower, California, United States +76 more locations

A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)

Colorectal Cancer Trials in Other Cities

Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer

Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy

Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer

Gene Testing in Patients With Colon Cancer

Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed

Screening Tests in Detecting Colorectal Cancer

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

FLU-FIT Program at Kaiser Permanente Northern California

A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

Permission to Collect Blood Over Time for Research

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

AANCART Research Project on Lay Health Workers and Asian Americans

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Other Conditions in San Francisco